Picture of Annexin Pharmaceuticals AB (publ) logo

ANNX Annexin Pharmaceuticals AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Annexin Pharmaceuticals AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-28.3-43.7-51.2-40.7-44.2
Non-Cash Items4.224.474.470.1930.193
Other Non-Cash Items
Changes in Working Capital-1.620.0661.74-0.6340.58
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-25.7-39.2-45-41.2-43.4
Capital Expenditures0000
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.0960-0.260.096
Change in Net Investments
Cash from Investing Activities0-0.0960-0.260.096
Financing Cash Flow Items0-7.62-10.3-0.047-2.9
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.22953.276.423.133.6
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2613.931.3-18.4-9.7
0